Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Roberto Guariglia, Maria Carmen Martorelli, Rosa Lerose, Donatella Telesca, Maria Rita Milella & Pellegrino Musto. (2016) Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients. Biologics: Targets and Therapy 10, pages 1-8.
Read now
Read now
Edouard Alphandéry, Pierre Grand-Dewyse, Raphael Lefèvre, Chalani Mandawala & Mickael Durand-Dubief. (2015) Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects. Expert Review of Anticancer Therapy 15:10, pages 1233-1255.
Read now
Read now
Jonathan Hoggatt & Louis M Pelus. (2014) New G-CSF agonists for neutropenia therapy. Expert Opinion on Investigational Drugs 23:1, pages 21-35.
Read now
Read now
Katharina Gunzer, Bénédicte Clarisse, Stéphanie Lheureux, Corinne Delcambre & Florence Joly. (2010) Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data. Expert Opinion on Biological Therapy 10:4, pages 615-630.
Read now
Read now
Articles from other publishers (15)
Zeinab Mohammadi, Mahdi Alijanianzadeh, Rassoul Khalilzadeh & Sirus Khodadadi. (2022)
Process Development for the Production and Purification of PEGylated
RhG-CSF Expressed in
Escherichia coli
. Protein & Peptide Letters 29:4, pages 293-305.
Crossref
Crossref
Donald J. AbrahamJonathan Hoggatt, Shruti Datari & Louis M. Pelus. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
42
.
Xiang Li, Huan Zheng, Man-Cheng Yu, Wei Wang, Xin-Hong Wu, Dong-Mei Yang & Juan Xu. (2020) Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis. Supportive Care in Cancer 28:11, pages 5085-5097.
Crossref
Crossref
Zaina T. Al-Salama & Susan J. Keam. (2019) Mecapegfilgrastim in Chemotherapy-Induced Neutropenia: A Profile of Its Use in China. Clinical Drug Investigation 39:10, pages 1009-1018.
Crossref
Crossref
Craig R. Wright, Alister C. Ward & Aaron P. Russell. (2017) Granulocyte Colony-Stimulating Factor and Its Potential Application for Skeletal Muscle Repair and Regeneration. Mediators of Inflammation 2017, pages 1-9.
Crossref
Crossref
Li-Wen Hsu, Toshiaki Nakano, Kuang-Tzu Huang, Chien-Chih Chen, Kuang-Den Chen, Chia-Yun Lai, Shih-Ming Yang, Chih-Che Lin, Chih-Chi Wang, Yu-Fan Cheng, King-Wah Chiu, Yur-Ren Kuo, Shigeru Goto & Chao-Long Chen. (2015) Prolonged survival by combined treatment with granulocyte colony-stimulating factor and dipeptidyl peptidase IV inhibitor in a rat small-for-size liver transplantation model. Hepatology Research 45:7, pages 804-813.
Crossref
Crossref
Mark P Rubinstein, Mohamed L Salem, Andrew L Doedens, Caitlin J Moore, Cody Chiuzan, Guillermo L Rivell, David J Cole & Ananda W Goldrath. (2013) G-CSF/anti-G-CSF antibody complexes drive the potent recovery and expansion of CD11b+Gr-1+ myeloid cells without compromising CD8+ T cell immune responses. Journal of Hematology & Oncology 6:1.
Crossref
Crossref
Bo Yan, Wei Zhang, Fang Lu, Zhong–Lin Chen, Bao–Hui Han & Li–Yan Jiang. (2013) Safety of polyethylene glycol recombinant human granulocyte colony-stimulating factor in treating non-small cell lung cancer patients at I b stage. Asian Pacific Journal of Tropical Medicine 6:11, pages 912-915.
Crossref
Crossref
Aleah L. Brubaker & Elizabeth J. Kovacs. (2013) G-CSF Enhances Resolution of Staphylococcus aureus Wound Infection in an Age-Dependent Manner. Shock 40:4, pages 327-333.
Crossref
Crossref
Adam Walker, Gráinne Dunlevy & Peter Topley. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
179
190
.
Bing-Bing Yang, Michael A. Savin & Michael Green. (2012) Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes. Chemotherapy 58:5, pages 387-398.
Crossref
Crossref
Jeremy D. Heidel & Mark E. Davis. (2010) Clinical Developments in Nanotechnology for Cancer Therapy. Pharmaceutical Research 28:2, pages 187-199.
Crossref
Crossref
Donald J. AbrahamLouis M. Pelus, Jonathan Hoggatt, Pratibha Singh & Janardhan Sampath. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
567
608
.
Matthew J. ParkerSong XueJohn J. AlexanderClive H. WasserfallMartha L. Campbell-ThompsonManuela BattagliaSilvia GregoriClayton E. MathewsSihong SongMisty TrouttScott EisenbeisJohn WilliamsDesmond A. SchatzMichael J. HallerMark A. Atkinson. (2009) Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice. Diabetes 58:10, pages 2277-2284.
Crossref
Crossref
Yanqin Zhai, Yongjiang Zhao, Jiandu Lei, Zhiguo Su & Guanghui Ma. (2009) Enhanced circulation half-life of site-specific PEGylated rhG-CSF: Optimization of PEG molecular weight. Journal of Biotechnology 142:3-4, pages 259-266.
Crossref
Crossref